Table of Content

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION & SCOPE 20
1.2.1 INCLUSIONS AND EXCLUSIONS 20
1.2.2 MARKETS COVERED 21
FIGURE 1 RNA ANALYSIS/TRANSCRIPTOMICS MARKET 21
1.2.3 YEARS CONSIDERED FOR THE STUDY 21
1.3 CURRENCY 22
1.4 STAKEHOLDERS 22
1.5 LIMITATIONS 22
1.6 SUMMARY OF CHANGES 22

2 RESEARCH METHODOLOGY 24
2.1 RESEARCH APPROACH 24
FIGURE 2 RESEARCH DESIGN 24
2.1.1 SECONDARY RESEARCH 25
2.1.1.1 Key data from secondary sources 26
2.1.2 PRIMARY RESEARCH 27
FIGURE 3 PRIMARY SOURCES 27
2.1.2.1 Key data from primary sources 28
2.1.2.2 Breakdown of primaries 28
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 28
2.2 MARKET SIZE ESTIMATION 29
FIGURE 5 SEGMENTAL SHARE ANALYSIS ILLUSTRATION 29
FIGURE 6 TOP-DOWN APPROACH 30
2.3 DATA TRIANGULATION APPROACH 32
FIGURE 7 DATA TRIANGULATION METHODOLOGY 32
2.4 MARKET SHARE ESTIMATION 33
2.5 ASSUMPTIONS FOR THE STUDY 33

3 EXECUTIVE SUMMARY 34
FIGURE 8 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE,
2020 VS. 2025 (USD MILLION) 34
FIGURE 9 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION) 35
FIGURE 10 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 36
FIGURE 11 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 37
FIGURE 12 GEOGRAPHIC ANALYSIS: RNA ANALYSIS/TRANSCRIPTOMICS MARKET 38

4 PREMIUM INSIGHTS 40
4.1 RNA ANALYSIS/TRANSCRIPTOMICS MARKET OVERVIEW 40
FIGURE 13 INCREASING RESEARCH BEING CONDUCTED USING OMICS TECHNOLOGIES TO DRIVE MARKET GROWTH 40
4.2 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY 41
FIGURE 14 PCR SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET IN 2019 41
4.3 RNA ANALYSIS/TRANSCRIPTOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 42
FIGURE 15 MARKET IN CHINA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 42
4.4 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY REGION (2018–2025) 43
FIGURE 16 NORTH AMERICA WILL CONTINUE TO DOMINATE THE RNA ANALYSIS/TRANSCRIPTOMICS MARKET UNTIL 2025 43
4.5 RNA ANALYSIS/TRANSCRIPTOMICS MARKET: DEVELOPED VS. DEVELOPING MARKETS 44
FIGURE 17 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 44

5 MARKET OVERVIEW 45
5.1 INTRODUCTION 45
5.2 MARKET DYNAMICS 45
TABLE 1 RNA ANALYSIS/TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS 45
5.2.1 DRIVERS 46
5.2.1.1 Increasing demand for personalized medicine 46
FIGURE 18 LAUNCH OF PERSONALIZED MEDICINE PRODUCTS, 2008–2016 46
5.2.1.2 Increasing pharmaceutical and biotechnology R&D expenditure and government funding 47
FIGURE 19 R&D INVESTMENTS, BY COUNTRY, 2017 VS. 2018 (USD BILLION) 48
5.2.1.3 Growing applications of RNA sequencing in transcriptomics 48
5.2.2 RESTRAINTS 49
5.2.2.1 High capital investments 49
5.2.3 OPPORTUNITIES 49
5.2.3.1 High growth opportunities in emerging markets 49
5.2.3.2 Increasing application of toxicogenomics 50
5.2.3.3 Increasing focus on biomarker discovery 50
5.2.3.4 Rising focus on outsourcing 51
5.2.4 CHALLENGES 51
5.2.4.1 Data management in transcriptomics research 51
5.2.4.2 Lack of effective bioinformatics tools 52
5.2.4.3 Dearth of skilled professionals 52
_

6 INDUSTRY INSIGHTS 53
6.1 INTRODUCTION 53
6.2 INDUSTRY TRENDS 53
6.2.1 INTEGRATION OF OMICS DATA IN BIOMEDICAL SCIENCES 53
6.2.2 GROWING FOCUS ON MONITORING POST-TRANSLATIONAL MODIFICATIONS 54
6.2.3 SHIFT FROM PLANT-BASED TO GENOME-BASED DRUG DISCOVERY 54
6.2.4 SPATIALLY RESOLVED TRANSCRIPTOMES 55
6.3 STRATEGIC BENCHMARKING 55
TABLE 2 PRODUCT PORTFOLIO ANALYSIS: RNA ANALYSIS/TRANSCRIPTOMICS MARKET 56
6.4 PORTER’S FIVE FORCES ANALYSIS 56
6.4.1 THREAT OF NEW ENTRANTS 56
6.4.2 THREAT OF SUBSTITUTES 57
6.4.3 BARGAINING POWER OF BUYERS 57
6.4.4 BARGAINING POWER OF SUPPLIERS 57
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 58
6.5 RELATED MARKET ANALYSIS 58
6.6 COVID-19 IMPACT ON THE RNA ANALYSIS/TRANSCRIPTOMICS MARKET 58

7 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE 60
7.1 INTRODUCTION 61
TABLE 3 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 61
7.2 REAGENTS/CONSUMABLES 61
7.2.1 REAGENTS/CONSUMABLES TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 61
TABLE 4 RNA ANALYSIS/TRANSCRIPTOMICS REAGENTS/CONSUMABLES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 63
7.3 INSTRUMENTS 63
7.3.1 THE NEED FOR ACCURATE ANALYSIS IS DRIVING THE ADOPTION OF AUTOMATED INSTRUMENTS 63
TABLE 5 RNA ANALYSIS/TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 64
7.4 SOFTWARE 65
7.4.1 NEED FOR DATA MANAGEMENT AND QUALITY ENHANCEMENTS OF RESULTS OBTAINED MAKES SOFTWARE SOLUTIONS AN IMPERATIVE PART OF TRANSCRIPTOMICS 65
TABLE 6 RNA ANALYSIS/TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 66
7.5 SERVICES 66
7.5.1 INCREASING OUTSOURCING OF SERVICES TO PROPEL MARKET GROWTH 66
TABLE 7 RNA ANALYSIS/TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 67
_

8 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY 68
8.1 INTRODUCTION 69
TABLE 8 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 69
8.2 POLYMERASE CHAIN REACTION 69
8.2.1 REAL-TIME PCR AIDS IN THE QUANTIFICATION OF LOW-COPY TRANSCRIPTS 69
TABLE 9 RNA ANALYSIS/TRANSCRIPTOMICS PCR MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 70
8.3 SEQUENCING 71
8.3.1 ADVANCES IN NGS MULTIPLEXING CAPABILITIES TO AID MARKET GROWTH 71
TABLE 10 RNA ANALYSIS/TRANSCRIPTOMICS SEQUENCING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 72
8.4 MICROARRAYS 72
8.4.1 WIDE ADOPTION OF MICROARRAYS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH 72
TABLE 11 RNA ANALYSIS/TRANSCRIPTOMICS MICROARRAYS MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 73
8.5 RNA INTERFERENCE (GENE SILENCING) 74
8.5.1 TECHNOLOGICAL ADVANCEMENTS ARE SUPPORTING THE ADOPTION OF THIS TECHNIQUE FOR DIAGNOSTICS AND THERAPEUTICS 74
TABLE 12 RNA ANALYSIS/TRANSCRIPTOMICS RNA INTERFERENCE MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 74

9 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION 75
9.1 INTRODUCTION 76
TABLE 13 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 76
9.2 DRUG DISCOVERY 76
9.2.1 TARGETED SEQUENCING-BASED APPROACHES ARE GAINING MOMENTUM IN THE FIELD OF DRUG DISCOVERY 76
FIGURE 20 R&D INVESTMENTS IN LIFE SCIENCES, 2016–2018 77
TABLE 14 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2018–2025 (USD MILLION) 78
9.3 CLINICAL DIAGNOSTICS 78
9.3.1 TRANSCRIPTOMICS IS WIDELY ADOPTED FOR THE LARGE-SCALE GENE EXPRESSION PROFILING OF ONCOLOGICAL DISORDERS 78
TABLE 15 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2018–2025 (USD MILLION) 80
9.4 TOXICOGENOMICS 80
9.4.1 INCREASING FOCUS ON ADR STUDIES IS DRIVING THE ADOPTION OF TRANSCRIPTOMICS FOR SYSTEMIC TOXICOLOGY 80
TABLE 16 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR TOXICOGENOMICS,
BY COUNTRY, 2018–2025 (USD MILLION) 81
9.5 COMPARATIVE TRANSCRIPTOMICS 82
9.5.1 TRANSCRIPTIONAL PROFILES ARE BEING WIDELY ADOPTED TO STUDY
THE EVOLUTION AMONG SPECIES 82
TABLE 17 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2018–2025 (USD MILLION) 83
10 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER 84
10.1 INTRODUCTION 85
TABLE 18 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 85
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 85
10.2.1 INCREASING INVESTMENTS FOR ONCOLOGY THERAPEUTICS DRIVING THE USE OF OMICS TECHNOLOGIES 85
TABLE 19 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 86
10.3 HOSPITALS & DIAGNOSTIC CENTERS 87
10.3.1 USE OF WHOLE-BLOOD TRANSCRIPTOME PROFILES FOR DISEASE DIAGNOSTICS IS AIDING MARKET GROWTH 87
TABLE 20 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2018–2025 (USD MILLION) 88
10.4 ACADEMIC & RESEARCH INSTITUTES 88
10.4.1 GROWING GOVERNMENT INVESTMENTS TO PROPEL MARKET GROWTH 88
TABLE 21 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 89
10.5 CONTRACT RESEARCH ORGANIZATIONS 90
10.5.1 GROWING OUTSOURCING SERVICES BY PHARMACEUTICAL COMPANIES FOR FASTER DRUG DISCOVERY IS AIDING MARKET GROWTH 90
TABLE 22 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 91

11 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY REGION 92
11.1 INTRODUCTION 93
FIGURE 21 RNA ANALYSIS/TRANSCRIPTOMICS MARKET: GEOGRAPHIC SNAPSHOT (2019) 93
TABLE 23 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY REGION,
2018–2025 (USD MILLION) 94
11.2 NORTH AMERICA 94
FIGURE 22 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET SNAPSHOT 95
TABLE 24 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 96
TABLE 25 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 96
TABLE 26 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 96
TABLE 27 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 97
TABLE 28 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY END USER, 2018–2025 (USD MILLION) 97
11.2.1 US 97
11.2.1.1 The US dominates the North American market 97
TABLE 29 US: NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020
(USD BILLION) 98
TABLE 30 US: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 98
TABLE 31 US: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 99
TABLE 32 US: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 99
TABLE 33 US: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 100
11.2.2 CANADA 100
11.2.2.1 Improving funding and infrastructure for omics-based research is supporting market growth 100
TABLE 34 CANADA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 101
TABLE 35 CANADA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 101
TABLE 36 CANADA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 102
TABLE 37 CANADA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 102
11.3 EUROPE 102
FIGURE 23 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET SNAPSHOT 104
TABLE 38 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 105
TABLE 39 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 105
TABLE 40 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 106
TABLE 41 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 106
TABLE 42 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 106
11.3.1 GERMANY 107
11.3.1.1 Germany holds the largest share of the European market 107
TABLE 43 GERMANY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 108
TABLE 44 GERMANY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 108
TABLE 45 GERMANY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 108
TABLE 46 GERMANY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 109
11.3.2 FRANCE 109
11.3.2.1 Increasing government support for omics-based research in the country to support market growth 109
TABLE 47 FRANCE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 110
TABLE 48 FRANCE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 110
TABLE 49 FRANCE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 111
TABLE 50 FRANCE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 111
11.3.3 UK 111
11.3.3.1 Rising public and private funding for research to drive market growth 111
TABLE 51 UK: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 112
TABLE 52 UK: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 113
TABLE 53 UK: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 113
TABLE 54 UK: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 113
11.3.4 ITALY 114
11.3.4.1 Growth in this market is driven by the improving R&D expenditure and disease diagnostics 114
TABLE 55 ITALY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 114
TABLE 56 ITALY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 115
TABLE 57 ITALY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 115
TABLE 58 ITALY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 115
11.3.5 SWITZERLAND 116
11.3.5.1 Well-established pharmaceutical industry to drive market growth 116
TABLE 59 SWITZERLAND: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 116
TABLE 60 SWITZERLAND: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 117
TABLE 61 SWITZERLAND: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 117
TABLE 62 SWITZERLAND: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 117
11.3.6 SPAIN 118
11.3.6.1 Increasing collaborations for enhancing research to support market growth 118
TABLE 63 SPAIN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 118
TABLE 64 SPAIN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 119
TABLE 65 SPAIN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 119
TABLE 66 SPAIN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 119
11.3.7 REST OF EUROPE 120
TABLE 67 ROE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 120
TABLE 68 ROE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 121
TABLE 69 ROE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 121
TABLE 70 ROE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 121
11.4 ASIA PACIFIC 122
FIGURE 24 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET SNAPSHOT 123
TABLE 71 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 124
TABLE 72 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 124
TABLE 73 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 124
TABLE 74 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 125
TABLE 75 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 125
11.4.1 JAPAN 125
11.4.1.1 Early adoption of technologically advanced products to drive
market growth 125
TABLE 76 JAPAN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 126
TABLE 77 JAPAN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 127
TABLE 78 JAPAN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 127
TABLE 79 JAPAN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 127
11.4.2 CHINA 128
11.4.2.1 China is one of the fastest-growing markets offering significant growth opportunities 128
TABLE 80 CHINA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 129
TABLE 81 CHINA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 129
TABLE 82 CHINA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 129
TABLE 83 CHINA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 130
11.4.3 INDIA 130
11.4.3.1 Increasing pharmaceutical R&D spending and government funding for research to drive market growth 130
TABLE 84 INDIA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 131
TABLE 85 INDIA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 131
TABLE 86 INDIA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 132
TABLE 87 INDIA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 132
11.4.4 REST OF ASIA PACIFIC 132
TABLE 88 ROAPAC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 133
TABLE 89 ROAPAC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 134
TABLE 90 ROAPAC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 134
TABLE 91 ROAPAC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 134
11.5 LATIN AMERICA 135
11.5.1 GROWTH IN THE PHARMACEUTICAL INDUSTRY IN MEXICO TO SUPPORT MARKET GROWTH 135
TABLE 92 LATIN AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 136
TABLE 93 LATIN AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 136
TABLE 94 LATIN AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 136
TABLE 95 LATIN AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 137
11.6 MIDDLE EAST & AFRICA 137
11.6.1 IMPROVING FOCUS ON PRECISION MEDICINE AND DISEASE GENETICS IS DRIVING MARKET GROWTH 137
TABLE 96 MIDDLE EAST & AFRICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 138
TABLE 97 MIDDLE EAST & AFRICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 138
TABLE 98 MIDDLE EAST & AFRICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 139
TABLE 99 MIDDLE EAST & AFRICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY END USER, 2018–2025 (USD MILLION) 139

12 COMPETITIVE LANDSCAPE 140
12.1 OVERVIEW 140
FIGURE 25 PRODUCT LAUNCHES?KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM JANUARY 2017 TO OCTOBER 2020 141
12.2 MARKET SHARE ANALYSIS 142
FIGURE 26 NGS MARKET SHARE, BY KEY PLAYER, 2019 142
FIGURE 27 PCR MARKET SHARE, BY KEY PLAYER, 2019 143
12.3 COMPANY EVALUATION MATRIX 143
12.3.1 STARS 143
12.3.2 EMERGING LEADERS 144
12.3.3 PERVASIVE 144
12.3.4 EMERGING COMPANIES 144
FIGURE 28 RNA ANALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 145
12.4 COMPETITIVE SITUATION AND TRENDS 146
12.4.1 PRODUCT LAUNCHES 146
TABLE 100 PRODUCT LAUNCHES, 2017–2020 146
12.4.2 EXPANSIONS 146
TABLE 101 EXPANSIONS, 2017–2020 146
12.4.3 ACQUISITIONS 147
TABLE 102 ACQUISITIONS, 2017–2020 147
12.4.4 OTHER STRATEGIES 148
TABLE 103 OTHER STRATEGIES, 2017–2020 148

13 COMPANY PROFILES 149
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 THERMO FISHER SCIENTIFIC, INC. 149
FIGURE 29 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019) 149
13.2 AGILENT TECHNOLOGIES, INC. 153
FIGURE 30 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019) 153
13.3 BIO-RAD LABORATORIES, INC. 157
FIGURE 31 BIO-RAD LABORATORIES, INC: COMPANY SNAPSHOT (2019) 157
13.4 CD GENOMICS 159
13.5 PROMEGA CORPORATION 160
13.6 ILLUMINA, INC. 161
FIGURE 32 ILLUMINA, INC.: COMPANY SNAPSHOT (2019) 161
13.7 QIAGEN N.V. 164
FIGURE 33 QIAGEN N.V.: COMPANY SNAPSHOT (2019) 164
13.8 DANAHER CORPORATION 166
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 166
13.9 F. HOFFMANN-LA ROCHE LTD. 169
FIGURE 35 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2019) 169
13.10 MERCK KGAA 171
FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2019) 171
13.11 FLUIDIGM CORPORATION 174
FIGURE 37 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2019) 174
13.12 EUROFINS SCIENTIFIC 176
FIGURE 38 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019) 176
13.13 SEQUENTIA BIOTECH SL 178
13.14 ACOBIOM 179
13.15 GENXPRO GMBH 180
13.16 OTHER COMPANIES 181
13.16.1 LEXOGEN GMBH 181
13.16.2 CENIX BIOSCIENCE GMBH 183
13.16.3 TAKARA HOLDINGS, INC. 184
13.16.4 BIOM?RIEUX SA 185
13.16.5 LC SCIENCES, LLC 186
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

14 APPENDIX 187
14.1 INSIGHTS OF INDUSTRY EXPERTS 187
14.2 DISCUSSION GUIDE 188
14.4 AVAILABLE CUSTOMIZATIONS 195
14.5 RELATED REPORTS 195
14.6 AUTHOR DETAILS 196